WallStSmart
SER

Serina Therapeutics Inc

NYSE MKT: SER · HEALTHCARE · BIOTECHNOLOGY

$1.83
-1.08% today

Updated 2026-04-29

Market cap
$27.26M
P/E ratio
P/S ratio
209.73x
EPS (TTM)
$-1.91
Dividend yield
52W range
$1 – $8
Volume
4.0M

Serina Therapeutics Inc (SER) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
-3.5%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+12.9%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-5.1%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-14.5%
2026-03-30
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-30$-0.31+38.0%$2.27$1.94-14.5%
2025-11-10$-0.51+3.1%$3.91$4.08+4.3%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.50$-0.31+38.0%
2025-09-30$-0.53$-0.51+3.1%
2025-06-30$-0.43$-0.66-55.3%$130000.00+154.9%
2025-03-31$-0.49$-0.49+0.0%
2024-12-31$0.42$-0.36-184.8%$-14000.00-100.5%
2024-09-30$0.13$14000.00-51.7%
2024-06-30$0.51$51000.00+628.6%
2024-03-31$-3.38$5000.00-83.3%
2023-12-31$-3.20$3.09M
2023-09-30$-5.01$29000.00
2023-06-30$-2.47$7000.00
2023-03-31$-3.04$30000.00

Frequently asked questions

Has Serina Therapeutics Inc beaten earnings estimates?
Serina Therapeutics Inc has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of -3.5% over the last 4 quarters.
How does SER stock react to earnings?
SER stock has moved an average of -5.1% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.